• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

供人类使用的胰岛素眼药水的可行性。

Feasibility of insulin eyedrops for human use.

作者信息

Liu S X, Chiou G C

机构信息

Department of Medical Pharmacology and Toxicology, Texas A&M University, College of Medicine, College Station.

出版信息

J Ocul Pharmacol. 1994 Fall;10(3):587-90. doi: 10.1089/jop.1994.10.587.

DOI:10.1089/jop.1994.10.587
PMID:7836868
Abstract

To determine the minimum effective concentration of insulin eyedrops for human use, insulin eyedrops at 0.01%, 0.05%, and 0.25% plus 0.5% Brij-78 were instilled into rabbit eyes. Brij-78 (0.5%) eyedrops were instilled as control. It was found that very low concentrations of insulin such as 0.05% plus 0.5% Brij-78 can reduce the blood glucose effectively in rabbits. The 0.05% insulin with 0.5% Brij-78 seems to be the best choice. Assuming the human body weight is approximately 25 times that of the rabbit, the concentration of insulin to be used for human patients would be 1.25% insulin (0.05% x 25), which is equivalent to 1.25 mg insulin/75 kg body weight. Because the absorption rate of insulin eyedrops plus Brij-78 is approximately 60-70%, 1.25% insulin plus Brij-78 would easily reach the therapeutic dose of insulin by injection (0.4-0.5 mg/75 kg). These results indicate that it is feasible to use insulin eyedrops to lower the blood glucose in humans. There was no statistical difference in blood glucose levels between animals instilled with 0.5% Brij-78 alone as control and those instilled with 0.01% insulin plus 0.5% Brij-78.

摘要

为确定人用胰岛素滴眼液的最低有效浓度,将含0.01%、0.05%和0.25%胰岛素加0.5%月桂醇聚醚-78的胰岛素滴眼液滴入兔眼。滴入含0.5%月桂醇聚醚-78的滴眼液作为对照。结果发现,极低浓度的胰岛素如0.05%加0.5%月桂醇聚醚-78可有效降低兔的血糖。含0.5%月桂醇聚醚-78的0.05%胰岛素似乎是最佳选择。假设人体重约为兔体重的25倍,用于人类患者的胰岛素浓度应为1.25%胰岛素(0.05%×25),相当于1.25毫克胰岛素/75千克体重。由于加了月桂醇聚醚-78的胰岛素滴眼液的吸收率约为60 - 70%,1.25%胰岛素加月桂醇聚醚-78很容易达到注射用胰岛素的治疗剂量(0.4 - 0.5毫克/75千克)。这些结果表明,使用胰岛素滴眼液降低人体血糖是可行的。单独滴入0.5%月桂醇聚醚-78作为对照的动物与滴入0.01%胰岛素加0.5%月桂醇聚醚-78的动物之间血糖水平无统计学差异。

相似文献

1
Feasibility of insulin eyedrops for human use.供人类使用的胰岛素眼药水的可行性。
J Ocul Pharmacol. 1994 Fall;10(3):587-90. doi: 10.1089/jop.1994.10.587.
2
Adjustment of blood sugar levels with insulin and glucagon eyedrops in normal and diabetic rabbits.
J Ocul Pharmacol. 1990 Fall;6(3):233-41. doi: 10.1089/jop.1990.6.233.
3
Chronic systemic delivery of insulin through the ocular route.通过眼部途径进行胰岛素的慢性全身给药。
J Ocul Pharmacol. 1993 Spring;9(1):85-90. doi: 10.1089/jop.1993.9.85.
4
Efficacy of insulin eyedrops.
J Ocul Pharmacol. 1994 Summer;10(2):461-70. doi: 10.1089/jop.1994.10.461.
5
Feasibility of glucagon eyedrops for clinical use in hypoglycemia.胰高血糖素滴眼液用于临床低血糖症的可行性。
J Ocul Pharmacol Ther. 1995 Fall;11(3):279-82. doi: 10.1089/jop.1995.11.279.
6
Alternative delivery of insulin via eye drops.通过眼药水进行胰岛素的替代给药。
Diabetes Technol Ther. 2005 Oct;7(5):695-8. doi: 10.1089/dia.2005.7.695.
7
Systemic absorption of insulin and glucagon applied topically to the eyes of rats and a diabetic dog.将胰岛素和胰高血糖素局部应用于大鼠和一只糖尿病犬的眼部后的全身吸收情况。
J Ocul Pharmacol Ther. 1995 Fall;11(3):283-95. doi: 10.1089/jop.1995.11.283.
8
Delivery of systemic regular insulin via the ocular route in cats.通过眼部途径在猫体内递送全身性常规胰岛素。
J Ocul Pharmacol Ther. 1995 Winter;11(4):565-73. doi: 10.1089/jop.1995.11.565.
9
Systemic delivery of insulin through eyes to lower the glucose concentration.通过眼睛进行胰岛素的全身递送以降低血糖浓度。
J Ocul Pharmacol. 1989 Spring;5(1):81-91. doi: 10.1089/jop.1989.5.81.
10
Enhancement of systemic delivery of met-enkephalin and leu-enkephalin eyedrops with permeation enhancers.
Methods Find Exp Clin Pharmacol. 1992 Jun;14(5):361-6.

引用本文的文献

1
Using Corneal Confocal Microscopy to Identify Therapeutic Agents for Diabetic Neuropathy.使用角膜共焦显微镜鉴定糖尿病神经病变的治疗药物。
J Clin Med. 2022 Apr 21;11(9):2307. doi: 10.3390/jcm11092307.
2
Topical Delivery of Muscarinic Receptor Antagonists Prevents and Reverses Peripheral Neuropathy in Female Diabetic Mice.局部给予毒蕈碱受体拮抗剂可预防和逆转雌性糖尿病小鼠的周围神经病变。
J Pharmacol Exp Ther. 2020 Jul;374(1):44-51. doi: 10.1124/jpet.120.265447. Epub 2020 Apr 23.
3
Ocular Complications of Diabetes and Therapeutic Approaches.
糖尿病的眼部并发症及治疗方法
Biomed Res Int. 2016;2016:3801570. doi: 10.1155/2016/3801570. Epub 2016 Mar 28.